微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | 5.42% | 39.33% | 63.25% | 58/159 | 4.1% | 迪哲医药 | 115.44% | 行业排名> |
| 2026-06-30 | 3.32% | 47.56% | -25.39% | 53/159 | 1.36% | 泽璟制药 | 44.02% | 行业排名> |
| 2026-03-31 | 4.45% | 75.89% | 1.83% | 15/159 | 0.06% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-12-31 | 4.37% | 30.06% | 12.34% | 63/159 | -4.32% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-09-30 | 3.89% | 62.76% | 72.89% | 74/159 | 1.69% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 2.25% | 47.06% | -11.07% | 78/159 | 0.34% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 2.53% | -31.06% | -24.7% | 40/159 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 3.36% | -31.15% | 40.59% | 73/159 | -9.4% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 2.39% | -59.63% | 56.21% | 95/159 | 4.26% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 1.53% | -75.94% | -58.31% | 94/159 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 3.67% | -40.03% | -24.8% | 22/159 | 2.33% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 4.88% | -45.78% | -17.57% | 64/159 | -0.94% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 5.92% | 17.46% | -6.92% | 57/159 | 2.36% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 6.36% | 112.71% | 3.92% | 23/159 | 1.49% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 6.12% | 93.67% | -32% | 4/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 9% | 224.91% | 78.57% | 47/159 | 0.84% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 5.04% | 25.69% | 68.56% | 63/159 | 2.87% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 2.99% | -14.81% | -5.38% | 67/159 | 2.21% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 3.16% | 10.88% | 14.08% | 33/159 | 1.59% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 2.77% | 109.5% | -30.92% | 92/159 | 0.87% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 4.01% | 213.6% | 14.25% | 86/159 | 4.45% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 3.51% | 2407.14% | 23.16% | 72/159 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 2.85% | 295.83% | 109.78% | 45/159 | 2.48% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | -29.15% | -810.98% | -725.78% | 134/159 | 3.82% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | -3.53% | -240.08% | -2621.43% | 103/159 | 3.15% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 0.14% | -92.47% | -80.56% | 108/159 | 4.28% | 中哲精化 | 45.32% | 行业排名> |
| 2020-03-31 | 0.72% | -62.69% | -82.44% | 76/159 | 2.23% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 4.1% | -25.05% | 62.7% | 94/159 | 2.62% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 2.52% | -3.08% | 35.48% | 91/159 | 7.58% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 1.86% | 2.2% | -3.63% | 89/159 | 5.02% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 1.93% | 2.12% | -64.72% | 58/159 | 2.44% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 5.47% | -32.72% | 110.38% | 82/159 | 7.16% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 2.6% | -64.67% | 42.86% | 86/159 | 7.2% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 1.82% | -36.81% | -3.7% | 83/159 | 4.62% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 1.89% | 235% | -76.75% | 59/159 | 2.57% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 8.13% | 79.87% | 10.46% | 63/159 | 9.61% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 7.36% | 83.54% | 155.56% | 45/159 | 8.3% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 2.88% | 19.01% | 305.71% | 72/159 | 5.55% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | -1.4% | -318.75% | -130.97% | 85/159 | 2.11% | 中哲精化 | 54.24% | 行业排名> |
| 2016-12-31 | 4.52% | -11.02% | 12.72% | 85/159 | 6.11% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 4.01% | -18% | 65.7% | 58/159 | 5.7% | ST南新 | 81.7% | 行业排名> |
| 2016-06-30 | 2.42% | -41.12% | 278.13% | 64/159 | 3.56% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 0.64% | -81.4% | -87.4% | 65/159 | 2.69% | 贝达药业 | 16.78% | 行业排名> |